Marksans Pharma Limited — Others, 13-08-2025: Copy of Newspaper Publication

**Marksans Pharma Limited:**

Marksans Pharma has informed stakeholders about the publication of newspaper advertisements detailing its un-audited financial results for the quarter ended June 30, 2025. This release makes the company's latest quarterly performance figures accessible to the public, offering vital transparency. Investors should review these results to gain an understanding of the company's recent operational trends, revenue generation, and profitability, which are key indicators for evaluating its short-term financial trajectory and informing investment assessments.

**KIDUJA INDIA LIMITED:**

Kiduja India Limited has declared its financial results for the quarter ended June 30, 2025. The company reported a Total Revenue of 19.12 Cr. Profit After Tax stood at 16.24 Cr, and Earnings per Share (EPS) were 6.77. These figures provide a snapshot of the company's recent financial performance, highlighting its revenue growth and profitability during the period. Investors should note these results for their assessment of the company's operational strength and financial health.

**CARYSIL LIMITED:**

Carysil Limited has released its consolidated financial results for the quarter ended June 30, 2025. The company posted a Total Revenue from Operations of 228.25 Cr. Net Profit After Tax for the period was 22.91 Cr, resulting in Earnings per Share (EPS) of 8.03. These outcomes offer a clear picture of Carysil's recent performance, reflecting its revenue generation and overall profitability. Investors should analyze these figures to gauge the company's operational efficiency and its trajectory for the current fiscal year.

**Ulundurpet Expressways Private Limited:**

Ulundurpet Expressways Private Limited has filed a petition with the National Company Law Tribunal for a reduction in its equity share capital. The company plans to reduce 5,38,79,400 equity shares, returning INR 18.56 per share to shareholders, totaling approximately INR 100.00 Cr. This move will adjust the difference between cancelled share face value and amount paid against retained earnings. Creditors have three months from the notice date to submit objections. This corporate action directly impacts the company's capital structure and shareholder value.